Search

everythinglearnresearchcommunity

for

Search:↓

Pancreatic cancer pain management is inadequate due to the disease's severity and limited effectiveness of treatments.

Norethisterone (jenapharm) therapy is effective for endometrial cancer.

Testosterone metabolism in balding scalp cells may not be the main cause of hair loss.

Myo-inositol supplements may improve insulin sensitivity and help with conditions like PCOS and gestational diabetes, but more research is needed.

Human skin can make serotonin and melatonin, which help protect and maintain it.

Understanding where cancer cells come from helps create better prevention and treatment methods.

Women with PCOS have overall higher body fat, not abnormal fat placement, and more insulin resistance.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Disrupting Smad4 in mouse skin causes early hair follicle stem cell activity that leads to their eventual depletion.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Loss of sebaceous glands and inflammation may contribute to the development of scarring alopecia.

CD98hc's role in skin health decreases with age.

Bridging anticoagulation may raise post-surgery bleeding risks.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Erlotinib can cause hair loss as a side effect.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Patients with chronic renal failure on hemodialysis often have skin problems like dry skin, itching, and nail changes.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

sPLA2-IIA increases growth in hair follicle stem cells and cancer cells, suggesting it could be targeted for hair growth and cancer treatment.

A dog's skin calcification condition resolved without treatment after a bacterial infection.

A patient with zinc depletion improved after zinc supplementation during parenteral nutrition.